α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease (Q84979636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease (English)

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

6 July 2024

1 reference

3

Jeffrey H Kordower

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Yaping Chu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Amanda L. Mickiewicz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816781

6 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816781

6 July 2024

publication date

9 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 February 2020

https://api.elsevier.com/content/article/PII:S0969996110002949?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

https://api.elsevier.com/content/article/PII:S0969996110002949?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

6 July 2024

published in

Neurobiology of Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

71-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

Temporal and regional evolution of aquaporin-4 expression and magnetic resonance imaging in a rat pup model of neonatal stroke

13 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins

6 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Staging of brain pathology related to sporadic Parkinson's disease

6 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Proteasome inhibition elicits a biphasic effect on neuronal apoptosis via differential regulation of pro-survival and pro-apoptotic transcription factors

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Lewy body pathology in fetal grafts

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Nurr1 in Parkinson's disease and related disorders

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Chaperone-Mediated Autophagy

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

A Drosophila model of Parkinson's disease

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

6 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Alpha-synuclein and neurodegenerative diseases

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons.

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

The expression of MEF2 genes is implicated in CNS neuronal differentiation

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Neuronal activity-dependent cell survival mediated by transcription factor MEF2

6 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

6 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Alpha-synuclein and Parkinson's disease

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

alpha-Synuclein locus triplication causes Parkinson's disease

6 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.

6 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Alpha-synuclein in Lewy bodies

6 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.

6 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.

6 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy

6 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NBD.2010.08.022

6 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20816781%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference